A Long-term Extension Study of PCI-32765 (Ibrutinib)
for Chronic Lymphocytic Leukemia
Drug: Ibrutinib
32 locations incl. Duarte
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT01804686·Phase 3·Recruiting
As of June 2026, 164 paid clinical trials are recruiting in Westwood, Kansas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .